Big data can benefit rheumatology research. But according to experts at the 2018 ACR/ARHP Annual Meeting, the data must first be accessible, interoperable and shareable…... [Read More]
Big Data Drives New Research
Search results for: Big data
Big Data May Shift Reference Ranges for Some Lab Tests
How will big data mined from huge sample sizes in research cohorts, electronic health records, personal health data (e.g., heart rates from Fitbits) and insurance claim data sets change the way physicians interpret something as simple as complete blood count (CBC) test results for individual patients? According to the authors of a paper in the… [Read More]
Thinking Big, Thinking Small
I would like to tell you a story. Two, actually. I am just returning from the 19th International Vasculitis and ANCA Workshop, which is always a fascinating meeting. In its inception, it was a workshop, in the true sense of the word. Now, we discuss anti-neutrophil cytoplasmic antibody (ANCA) testing as casually as we discuss… [Read More]
More Data for Treat to Target: Post-Hoc Analysis of Large RA Clinical Trials Supports Treat-to-Target Recommendations
A post-hoc analysis of data from two large clinical trials supports treat-to-target recommendations for patients with rheumatoid arthritis. The research found baseline disease activity was the strongest predictor of a patient’s insufficient response to initial therapy at six months…... [Read More]
How Decentralized Technology May Revolutionize Data in Healthcare
Rheumatologists may benefit from the decentralized technology that makes cryptocurrency possible: blockchain. According to Anh L. Ngo, MD, MBA, using blockchain in healthcare may increase payment and purchasing efficiency and revolutionize EHR management…... [Read More]
RISE Lifts Research: The 2018 Annual Meeting Features 6 New Studies Based on RISE Data
Data from the ACR’s Rheumatology Informatics System for Effectiveness (RISE) were used by rheumatology researchers in a crop of new studies that will be presented at the 2018 ACR/ARHP Annual Meeting, Oct. 19–24 in Chicago. Six abstracts, including four oral and two poster presentations, were accepted for this year’s meeting. They explore topics ranging from… [Read More]
RISE Dashboard Updates Help Users Report 2018 MIPS Data
As the year begins to wind down, Zach McMurray is gearing up for 2018 MIPS reporting. Despite the “always changing and usually confusing landscape of MACRA/MIPS,” he says his practice isn’t worried because it uses the ACR’s Rheumatology Informatics System for Effectiveness (RISE) qualified clinical data registry. Mr. McMurray is director of clinical information systems… [Read More]
Fed Up with Rising Costs, Big U.S. Firms Dig Into Healthcare
SAN JOSE, Calif., (Reuters)—At its Silicon Valley headquarters, network gear maker Cisco Systems Inc. is going to unusual lengths to take control of the relentless increase in its U.S. healthcare costs. The company is among a handful of large American employers who are getting more deeply involved in managing their workers’ health instead of looking… [Read More]
Avoid Errors: Insights into Ensuring Accurate Data in EHRs
With the increasing use of electronic health records and quality measure reporting requirements, data collection has become crucial for rheumatologists. But how do clinicians prevent human error and ensure data accuracy?... [Read More]
Romosozumab Has Biggest BMD Benefit in First Year of Treatment
NEW YORK (Reuters Health)—Romosozumab shows smaller benefits for increasing bone mineral density (BMD) in the second year of treatment compared to the first, new research suggests. The extension of a phase 2 study in postmenopausal women with low bone mass also found BMD decreased sharply when patients on romosozumab were switched to placebo after two… [Read More]
- 1
- 2
- 3
- …
- 37
- Next Page »